The global “Digital PCR Market” is forecast to reach USD 799.1 million by 2026, attributed to the increasing prevalence of infectious diseases and genetic disorders worldwide. Digital PCR is the biotechnological advancement of conventional PCR and provides a reproducible and sensitive method of measuring the amount of RNA or DNA in a sample. Fortune Business Insights discusses the market and its growth trajectories in a recently published report titled, “Digital PCR Market Size, Share & Industry Analysis, By Type (Droplet Digital PCR, Chip-based Digital PCR, and Others), By Product (Instruments and Reagents & Consumables), By Indication (Infectious Diseases, Oncology, Genetic Disorders, and Others), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Industries, Diagnostic Centers, and Academic & Research Organizations), and Regional Forecast, 2019-2026”.

According to this report, the market value was USD 224.9 million in 2018 and is likely to exhibit a CAGR of 17.2% within the forecast period of 2019 to 2026.

Major Digital PCR Market Key players covered in the report include:

  • Qiagen
  • JN Medsys
  • Merck KGaA
  • Fluidign Corporation
  • Stilla Technologies
  • Thermo Fisher Scientific Inc.
  • Sysmex Inostics
  • Bio-Rad Laboratories Inc.
  • Other Players

Get Request a Sample Copy of the Digital PCR Report:

https://www.fortunebusinessinsights.com/enquiry/sample/digital-pcr-market-102014

Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for market to figure out and study the market’s needs, market size, and competition.

Digital PCR Market Analysis 2021:

Market Drivers and Restraints

Rise in Prevalence of Genetic Disorders to Aid in Expansion of Market

The increasing prevalence of infectious and genetic diseases is a major digital polymerase chain reaction market growth driver. In addition to this, the advancement in medical technology and introduction of innovative devices for therapeutic purposes will also aid in expansion of the market in the coming years. These innovative devices include crystal dPCR, beam dPCR chip-based digital PCR, and droplet digital PCR.

On the other side, high cost of digital polymerase chain reaction installation may pose a major challenge to the market growth. This, coupled with the lack of awareness about the availability of treatment options, especially in developing and under-developed nations, may hamper the overall market in the coming years.

Nevertheless, the gradual shift towards chip-based dPCR from droplet dPCR by healthcare providers is expected to boost the market in the coming years.

Regional Segmentation:

Increasing Prevalence of Genetic Disorders to help Asia Pacific Register Faster CAGR by 2026

As per geographical segmentation, North America earned the largest digital polymerase chain reaction market share with a revenue of USD 96.5 million earned in 2018. This is owing to the high prevalence and diagnosis rate of infectious disease and the availability of better healthcare facilities in the region. In addition, there is high awareness among people about the availability of advanced dPCR devices as treatment options in the developed nations of the region. Furthermore, the increasing number of various cancer cases and metabolic diseases are also boosting the regional market.

On the other side, Asia Pacific market is anticipated to witness the fastest CAGR in the forthcoming years on account of the developing healthcare infrastructure and medical facilities and increasing prevalence of genetic and infectious diseases.

For more information in the analysis of this report, visit: 

https://www.fortunebusinessinsights.com/digital-pcr-market-102014